- Report
- February 2025
- 103 Pages
Europe
From €5380EUR$5,995USD£4,721GBP
- Report
- February 2025
- 73 Pages
North America
From €5380EUR$5,995USD£4,721GBP
- Report
- June 2025
- 182 Pages
United States
From €5380EUR$5,995USD£4,721GBP
- Report
- June 2025
- 92 Pages
Europe
From €3544EUR$3,950USD£3,111GBP
- Report
- May 2025
- 76 Pages
Middle East, Africa
From €2647EUR$2,950USD£2,323GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3096EUR$3,450USD£2,717GBP
- Report
- May 2025
- 98 Pages
Europe
From €3096EUR$3,450USD£2,717GBP
- Report
- May 2025
- 88 Pages
North America
From €2647EUR$2,950USD£2,323GBP
- Report
- January 2020
- 473 Pages
Global
From €4396EUR$4,899USD£3,858GBP
- Report
- September 2024
- 593 Pages
Global
From €4306EUR$4,799USD£3,779GBP
- Report
- October 2018
- 450 Pages
Global
From €3140EUR$3,499USD£2,756GBP
- Report
- March 2024
- 329 Pages
Global
From €5130EUR$5,917USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5130EUR$5,917USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5130EUR$5,917USD£4,350GBP
- Report
- November 2024
- 185 Pages
Global
From €3455EUR$3,850USD£3,032GBP
- Report
- April 2022
- 250 Pages
Global
From €6147EUR$6,850USD£5,395GBP
- Report
- September 2021
- 100 Pages
Global
€3455EUR$3,850USD£3,032GBP
- Report
- May 2022
- 100 Pages
Global
From €1525EUR$1,700USD£1,339GBP
- Report
- September 2024
- 719 Pages
Global
From €4442EUR$4,950USD£3,898GBP
- Report
- July 2024
- 293 Pages
Global
From €4442EUR$4,950USD£3,898GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more